FDA
# EUA Revocations
`Revocation 'Pre-Omicron'
- Bamlanivimab monotherapy (w/o concomitant etesevimab)

`Revocation in Nationwide Omicron Domianance`
- Bamlanivimab
- Etesevimab 
- Casirivimab
- Imdevimab

# EUA Active
- Sotrovimab
- Tixagavimab
- Cilgavimab
